This is a standard initial ownership filing for a new officer. No actionable trading signal. Monitor future Form 4 filings for any insider transactions that may provide insight into management's view of the stock.
Price Chart
Executive Summary
Jing L. Marantz filed a Form 3 initial statement of beneficial ownership with the SEC, disclosing her role as EVP and Chief Medical Officer of Intellia Therapeutics. The filing is a routine insider ownership disclosure and includes a limited power of attorney authorizing others to file Section 16 reports on her behalf. No trading activity or change in economic exposure is reported.
Key Facts
- Jing L. Marantz filed a Form 3 on 2026-10-28, reporting as an officer (EVP, Chief Medical Officer) of Intellia Therapeutics.
- The filing includes a limited power of attorney appointing James Basta and Edward Dulac to execute Section 16 filings.
- No beneficial ownership amounts or transactions are disclosed in the filing documents.
Financial Impact
No financial impact; routine insider ownership disclosure with no stated holdings or transactions.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-436123 |
| Document: 0001193125-26-436123-index-headers.html | 0001193125-26-436123 |
| Document: 0001193125-26-436123-index.html | 0001193125-26-436123 |
| Document: 0001193125-26-436123.txt | 0001193125-26-436123 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 2d ago | Press Release | $13.23 | awaiting T+5 | awaiting T+5 | $12.47 (−5.74%) |
Oct 28, 2026 2d ago | 3 | $13.23 | awaiting T+5 | awaiting T+5 | $12.47 (−5.74%) |
Oct 2, 2026 28d ago | Press Release | $12.75 $12.58 | ▼ −1.33% | ▼ −1.76% | $12.47 (−2.20%) |
Sep 8, 2026 7w ago | 8-K | $12.21 $11.60 | ▼ −5.00% | ▼ −4.66% | $12.47 (+2.13%) |
Aug 6, 2026 12w ago | 8-K | $11.24 $11.83 | ▲ +5.25% | ▲ +4.04% | $12.47 (+10.94%) |
Jun 15, 2026 19w ago | 8-K | $14.92 $15.75 | ▲ +5.56% | ▲ +6.95% | $12.47 (−16.42%) |
Jun 13, 2026 19w ago | Press Release | $14.92 $15.75 | ▲ +5.56% | ▲ +6.95% | $12.47 (−16.42%) |
Jun 1, 2026 21w ago | Press Release | $13.73 $13.54 | ▼ −1.38% | ▲ +1.37% | $12.47 (−9.18%) |
May 11, 2026 24w ago | 8-K | $14.42 $12.69 | ▼ −12.00% | ▼ −11.91% | $12.47 (−13.52%) |
Apr 27, 2026 26w ago | Press Release | $13.20 $13.87 | ▼ −5.08% | ▼ −3.38% | $12.47 (+5.53%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers